Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb;11(1):e28-e29.
doi: 10.1212/CPJ.0000000000000751.

Transient Paralysis: A Novel Expression of Kratom Toxicity in Humans

Harold A Matos-Casano  1 , Sunanda Nanduri  1
Affiliations
Case Reports

Transient Paralysis: A Novel Expression of Kratom Toxicity in Humans

Harold A Matos-Casano et al. Neurol Clin Pract. 2021 Feb.
No abstract available

PubMed Disclaimer

References

    1. White CM. Pharmacologic and clinical assessment of kratom. Am J Health Syst Pharm 2018;75:261–267. - PubMed
    1. Chittrakarn S, Keawpradub N, Sawangjaroen K, Kansenalak S, Janchawee B. The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.). J Ethnopharmacol 2010;129:344–349. - PubMed
    1. Lydecker AG, Sharma A, McCurdy CR, Avery BA, Babu KM, Boyer EW. Suspected adulteration of commercial kratom products with 7-hydroxymitragynine. J Med Toxicol 2016;12:341–349. - PMC - PubMed
    1. Prozialeck WC, Avery BA, Boyer EW, et al. Kratom policy: the challenge of balancing therapeutic potential with public safety. Int J Drug Policy 2019;70:70–77. - PMC - PubMed
    1. Meireles V, Rosado T, Barroso M, et al. Mitragyna speciosa: clinical, toxicological aspects and analysis in biological and non-biological samples. Medicines (Basel) 2019;6:E35. - PMC - PubMed

Publication types